Praxis Investment Portfolios

Praxis Precision Medicines Gears Up for Phase 2 Results of Its Pioneering Epileptic Encephalopathies Treatment Sep 3, 2024

Praxis Precision Medicines Announces Participation in Investor Conferences May 18, 2024